Intrapulmonary targeting of RANTES/CCL5-responsive cells prevents chronic fungal asthma

European Journal of Immunology

Volumn 33, Issue 11, 2003, Pages 3080-3090

  Schuh, Jane M ^a   Blease, Kate ^a   Brühl, Hilke ^b   Mack, Matthias ^b   Hogaboam, Cory M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Airway hyperreactivity; Aspergillus fumigatus; Asthma; Chemokine receptor; RANTES

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHIMERIC PROTEIN; IMMUNOGLOBULIN E; PSEUDOMONAS EXOTOXIN; RANTES;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; ASTHMA; BRONCHUS REACTIVITY; CONIDIUM; CONTROLLED STUDY; DRUG TARGETING; EOSINOPHILIA; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; LUNG CLEARANCE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RESPIRATORY TRACT DISEASE; SENSITIZATION; T LYMPHOCYTE;

ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ASTHMA; CHRONIC DISEASE; FLOW CYTOMETRY; GOBLET CELLS; IMMUNOHISTOCHEMISTRY; LUNG; MICE; RANTES;

EID: 0242475331     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323917     Document Type: Article

References (37)

1. Schall, T. J., Jongstra, J., Dyer, B. J., Jorgensen, J., Clayberger, C., Davis, M. M. and Krensky, A. M., A human T cell-specific molecule is a member of a new gene family. J. Immunol. 1988. 141: 1018-1025.
2. Schall, T. J., Bacon, K., Toy, K. J. and Goeddel, D. V., Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990. 347: 669-671.
3. Alam, R., Stafford, S., Forsythe, P., Harrison, R., Faubion, D., Lett-Brown, M. A. and Grant, J. A., RANTES is a chemotactic and activating factor for human eosinophils. J. Immunol. 1993. 150: 3442-3448.
4. Folkard, S. G., Westwick, J. and Millar, A. B., Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics. Eur. Respir. J. 1997. 10: 2097-2104.
5. Chihara, J., Hayashi, N., Kakazu, T., Yamamoto, T., Kurachi, D. and Nakajima, S., RANTES augments radical oxygen products from eosinophils. Int. Arch. Allergy Immunol. 1994. 104 Suppl. 1: 52-53.
6. Chihara, J., Oyamada, H., Yamada, H., Tsuda, A., Kamada, Y. and Urayama, O., Expression of mRNA for RANTES in human eosinophils. Int. Arch. Allergy Immunol. 1997. 114 Suppl. 1: 33-35.
7. Hiura, T. S., Kempiak, S. J. and Nel, A. E., Activation of the human RANTES gene promoter in a macrophage cell line by lipopolysaccharide is dependent on stress-activated protein kinases and the IkappaB kinase cascade: implications for exacerbation of allergic inflammation by environmental pollutants [see comments]. Clin. Immunol. 1999. 90: 287-301.
8. Pype, J. L., Dupont, L. J., Menten, P., Van Coillie, E., Opdenakker, G., Van Damme, J., Chung, K. F., Demedts, M. G. and Verladen, G. M., Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines. Am. J. Respir Cell Mol. Biol. 1999. 21: 528-536.
9. Teran, L. M., Mochizuki, M., Bartels, J., Valencia, E. L., Nakajima, T., Hirai, K. and Schroder, J. M., Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 1999. 20: 777-786.
10. Propst, S. M., Denson, R., Rothstein, E., Estell, K. and Schwiebert, L. M., Proinflammatory and Th2-derived cytokines modulate CD40-mediated expression of inflammatory mediators in airway epithelia: implications for the role of epithelial CD40 in airway inflammation. J. Immunol. 2000. 165: 2214-2221.
11. Pakianathan, D. R., Kuta, E. G., Artis, D. R., Skelton, N. J. and Hebert, C. A., Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3 and CCR5. Biochemistry 1997. 36: 9642-9648.
12. Alam, R., York, J., Boyars, M., Stafford, S., Grant, J. A., Lee, J., Forsythe, P., Sim, T. and Ida, N., Increased MCP-1, RANTES, and MIP-1 alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. Am. J. Respir. Crit. Care Med. 1996. 153: 1398-1404.
13. Humbert, M., Ying, S., Corrigan, C., Menz, G., Barkans, J., Pfister, R., Meng, Q., Van Damme, J., Opdenakker, G., Durham, S. R. and Kay, A. B., Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3. Am. J. Respir. Cell Mol. Biol. 1997. 16: 1-8.
14. Tonnel, A. B., Gosset, P. and Tillie-Leblond, I., Characteristics of the inflammatory response in bronchial lavage fluids from patients with status asthmaticus. Int. Arch. Allergy Immunol. 2001. 124: 267-271.
15. Fryer, A. A., Spiteri, M. A., Bianco, A., Hepple, M., Jones, P. W., Strange, R. C., Makki, R., Tavernier, G., Smilie, F. I., Custovic, A., Woodcock, A. A., Ollier, W. E. and Hajeer, A. H., The -403 G→A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun. 2000. 11: 509-514.
16. Kimata, H., Yoshida, A., Ishioka, C., Fujimoto, M., Lindley, I. and Furusho, K., RANTES and macrophage inflammatory protein 1 alpha selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells. J. Exp. Med. 1996. 183: 2397-2402.
17. Venge, J., Lampinen, M., Hakansson, L., Rak, S. and Venge, P., Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J. Allergy Clin. Immunol. 1996. 97: 1110-1115.
18. Lampinen, M., Rak, S. and Venge, P., The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung. Clin. Exp. Allergy 1999. 29: 314-322.
19. Kuna, P., Alam, R., Ruta, U. and Gorski, P., RANTES induces nasal mucosal inflammation rich in eosinophils, basophils, and lymphocytes in vivo. Am. J. Respir. Crit. Care Med. 1998. 157: 873-879.
20. Sato, E., Simpson, K. L., Grisham, M. B., Koyama, S. and Robbins, R. A., Effects of reactive oxygen and nitrogen metabolites on RANTES- and IL-5-induced eosinophil chemotactic activity in vitro. Am. J. Pathol. 1999. 155: 591-598.
21. Boyce, J. A., The pathobiology of eosinophilic inflammation. Allergy Asthma Proc. 1997. 18: 293-300.
22. McKenzie, G. J., Bancroft, A., Grencis, R. K. and McKenzie, A. N., A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr. Biol. 1998. 8: 339-342.
23. Lukacs, N. W., Strieter, R. M., Warmington, K., Lincoln, P., Chensue, S. W. and Kunkel, S. L., Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by CC family chemokines in allergic airway inflammation. J. Immunol. 1997. 158: 4398-4404.
24. Gonzalo, J. A., Lloyd, C. M., Wen, D., Albar, J. P., Wells, T. N., Proudfoot, A., Martinez, A. C., Dorf, M., Bjerke, T., Coyle, A. J. and Gutierrez-Ramos, J. C., The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J. Exp. Med. 1998. 188: 157-167.
25. Bruhl, H., Cihak, J., Stangassinger, M., Schlondorff, D. and Mack, M., Depletion of CCR5-expressing cells with bispecific antibodies and chemokine toxins: a new strategy in the treatment of chronic inflammatory diseases and HIV. J. Immunol. 2001. 166: 2420-2426.
26. Holt, P. G., Macaubas, C., Stumbles, P. A. and Sly, P. D., The role of allergy in the development of asthma. Nature 1999. 402: B12-B17.
27. Skov, M., Poulsen, L. K. and Koch, C., Increased antigen-specific Th-2 response in allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis. Pediatr. Pulmonol. 1999. 27: 74-79.
28. +Th2-like T cell lines in allergic bronchopulmonary aspergillosis. J. Allergy Clin. Immunol. 1994. 94: 215-221.
29. Schuh, J. M., Blease, K. and Hogaboam, C. M., The role of CC chemokine receptor 5 (CCR5) and RANTES/CCL5 during chronic fungal asthma in mice. FASEB J. 2002. 16: 228-230.
30. Hogaboam, C. M., Blease, K., Mehrad, B., Steinhauser, M. L., Standiford, T. J., Kunkel, S. L. and Lukacs, N. W., Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am. J. Pathol. 2000. 156: 723-732.
31. -/- mice. FASEB J. 2002. 16: 1313-1315.
32. Plater-Zyberk, C., Hoogewerf, A. J., Proudfoot, A. E., Power, C. A. and Wells, T. N., Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol. Lett. 1997. 57: 117-120.
33. Teixeira, M. M., Wells, T. N., Lukacs, N. W., Proudfoot, A. E., Kunkel, S. L., Williams, T. J. and Hellewell, R G., Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J. Clin. Invest. 1997. 100: 1657-1666.
34. Chvatchko, Y., Hoogewerf, A. J., Meyer, A., Alouani, S., Juillard, P., Buser, R., Conquet, F., Proudfoot, A. E., Wells, T. N. and Power, C. A., A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock. J. Exp. Med. 2000. 191: 1755-1764.
35. Raport, C. J., Gosling, J., Schweickart, V. L., Gray, P. W. and Charo, I. F., Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha. J. Biol. Chem. 1996. 271: 17161-17166.
36. Blease, K., Jakubzick, C., Schuh, J. M., Joshi, B. H., Puri, R. K. and Hogaboam, C. M., IL-13 fusion cytotoxin ameliorates chronic fungal-induced allergic airway disease in mice. J. Immunol. 2001. 167: 6583-6592.
37. Evanoff, H., Burdick, M. D., Moore, S. A., Kunkel, S. L. and Strieter, R. M., A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1). Immunol. Invest. 1992. 21: 39-49.